Invention Grant
- Patent Title: Renal neuromodulation for treatment of patients
-
Application No.: US15476867Application Date: 2017-03-31
-
Publication No.: US09907611B2Publication Date: 2018-03-06
- Inventor: Howard R. Levin , Mark Gelfand
- Applicant: Medtronic Ardian Luxembourg S.a.r.l.
- Applicant Address: LU Luxembourg
- Assignee: Medtronic Ardian Luxembourg S.a.r.l.
- Current Assignee: Medtronic Ardian Luxembourg S.a.r.l.
- Current Assignee Address: LU Luxembourg
- Main IPC: A61B18/14
- IPC: A61B18/14 ; A61B18/04 ; A61M5/142 ; A61N1/05 ; A61N1/32 ; A61N1/36 ; A61N1/40 ; A61N5/00 ; A61M1/36 ; A61N1/362 ; A61M5/172 ; A61B18/00
Abstract:
A method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve. The goal of therapy is to reduce sympathetic activity of the renal nerve. Therapy is accomplished by at least partially blocking the nerve with drug infusion or electrostimulation. Apparatus can be permanently implanted or catheter based.
Public/Granted literature
- US20170265937A1 Renal Neuromodulation for Treatment of Patients Public/Granted day:2017-09-21
Information query
